SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-120962
Filing Date
2021-04-19
Accepted
2021-04-19 14:04:52
Documents
2
Group Members
JAY SCHMELTERJOHN P. MCKEARN, PH.D.NIALL O'DONNELL, PH.D.RIVERVEST VENTURE FUND III (OHIO), L.P.RIVERVEST VENTURE FUND IV, L.P.RIVERVEST VENTURE PARTNERS III (OHIO), LLCRIVERVEST VENTURE PARTNERS III, L.P.RIVERVEST VENTURE PARTNERS III, LLCRIVERVEST VENTU

Document Format Files

Seq Description Document Type Size
1 SC 13D d171374dsc13d.htm SC 13D 285407
2 EXHIBIT A d171374dex99a.htm EX-99.A 23050
  Complete submission text file 0001193125-21-120962.txt   310416
Mailing Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105
Business Address 7733 FORSYTH BOULEVARD ST. LOUIS MO 63105 314-726-6700
RiverVest Venture Fund III, L.P. (Filed by) CIK: 0001601559 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address P.O. BOX 675614 RANCHO SANTA FE CA 92067
Business Address P.O. BOX 675614 RANCHO SANTA FE CA 92067 619-733-3852
Reneo Pharmaceuticals, Inc. (Subject) CIK: 0001637715 (see all company filings)

IRS No.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92480 | Film No.: 21834015
SIC: 2834 Pharmaceutical Preparations